Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000037386 | SCV000061043 | uncertain significance | not specified | 2014-07-21 | criteria provided, single submitter | clinical testing | The Leu1611Phe variant in LAMA4 has been identified by our laboratory in 1 teena ger with DCM who carried a pathogenic variant in a different gene. It was absent from large population studies. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Leu1611Phe variant is uncertain. |
Invitae | RCV000545918 | SCV000654020 | likely benign | Dilated cardiomyopathy 1JJ | 2023-08-20 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000545918 | SCV000743160 | likely benign | Dilated cardiomyopathy 1JJ | 2017-07-28 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769189 | SCV000900565 | benign | Cardiomyopathy | 2018-07-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001551589 | SCV001772124 | uncertain significance | not provided | 2023-05-18 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27532257, 24503780) |
Ambry Genetics | RCV002336128 | SCV002639205 | likely benign | Cardiovascular phenotype | 2019-11-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003944910 | SCV004758292 | likely benign | LAMA4-related condition | 2019-11-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV001551589 | SCV001925103 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001551589 | SCV001955386 | likely benign | not provided | no assertion criteria provided | clinical testing |